Somatic Gastrointestinal Stromal Tumors (GIST) Panel

This panel analyzes key genes commonly mutated in GIST, including KIT, PDGFRA, SDH, and others. By pinpointing specific mutations, this panel aids in accurate diagnosis, prognosis, and the selection of targeted therapies, such as tyrosine kinase inhibitors. Comprehensive genetic profiling of GISTs enables personalized treatment strategies, which can significantly improve patient outcomes and disease management.